Mnyandu N, Limani S, Ely A, Wadee R, Arbuthnot P, Maepa M
Virol J. 2025; 22(1):41.
PMID: 39962472
PMC: 11834259.
DOI: 10.1186/s12985-025-02662-5.
Olenginski L, Attionu S, Henninger E, LeBlanc R, Longhini A, Dayie T
Viruses. 2023; 15(9).
PMID: 37766319
PMC: 10534774.
DOI: 10.3390/v15091913.
Bhat S, Ahanger I, Kazim S
ACS Omega. 2023; 8(16):14273-14289.
PMID: 37125123
PMC: 10134252.
DOI: 10.1021/acsomega.2c07154.
Hu J, Huang A
Microorganisms. 2023; 11(3).
PMID: 36985174
PMC: 10058911.
DOI: 10.3390/microorganisms11030600.
He P, Zhang P, Fang Y, Han N, Yang W, Xia Z
Mol Cell Biochem. 2023; 478(10):2297-2307.
PMID: 36735210
DOI: 10.1007/s11010-023-04660-z.
Approaches to quantifying hepatitis B virus covalently closed circular DNA.
Zhang H, Tu T
Clin Mol Hepatol. 2021; 28(2):135-149.
PMID: 34674513
PMC: 9013611.
DOI: 10.3350/cmh.2021.0283.
The Hepatitis B Virus Interactome: A Comprehensive Overview.
Van Damme E, Vanhove J, Severyn B, Verschueren L, Pauwels F
Front Microbiol. 2021; 12:724877.
PMID: 34603251
PMC: 8482013.
DOI: 10.3389/fmicb.2021.724877.
Chronic Hepatitis B Treatment Strategies Using Polymerase Inhibitor-Based Combination Therapy.
Ohsaki E, Suwanmanee Y, Ueda K
Viruses. 2021; 13(9).
PMID: 34578273
PMC: 8473100.
DOI: 10.3390/v13091691.
Early Steps of Hepatitis B Life Cycle: From Capsid Nuclear Import to cccDNA Formation.
Diogo Dias J, Sarica N, Neuveut C
Viruses. 2021; 13(5).
PMID: 33925977
PMC: 8145197.
DOI: 10.3390/v13050757.
Estimating hepatitis B virus cccDNA persistence in chronic infection.
Lythgoe K, Lumley S, Pellis L, McKeating J, Matthews P
Virus Evol. 2021; 7(1):veaa063.
PMID: 33732502
PMC: 7947180.
DOI: 10.1093/ve/veaa063.
cccDNA Maintenance in Chronic Hepatitis B - Targeting the Matrix of Viral Replication.
Dandri M, Petersen J
Infect Drug Resist. 2020; 13:3873-3886.
PMID: 33149632
PMC: 7605611.
DOI: 10.2147/IDR.S240472.
Single hepatocytes show persistence and transcriptional inactivity of hepatitis B.
Balagopal A, Grudda T, Ribeiro R, Saad Y, Hwang H, Quinn J
JCI Insight. 2020; 5(19).
PMID: 33004689
PMC: 7566712.
DOI: 10.1172/jci.insight.140584.
Hepatitis B virus cccDNA: Formation, regulation and therapeutic potential.
Xia Y, Guo H
Antiviral Res. 2020; 180:104824.
PMID: 32450266
PMC: 7387223.
DOI: 10.1016/j.antiviral.2020.104824.
Serum HBV RNA composition dynamics as a marker for intrahepatic HBV cccDNA turnover.
Hong X, Hu J
J Med Virol. 2020; 92(8):935-937.
PMID: 32320077
PMC: 7379877.
DOI: 10.1002/jmv.25925.
Rapid Turnover of Hepatitis B Virus Covalently Closed Circular DNA Indicated by Monitoring Emergence and Reversion of Signature-Mutation in Treated Chronic Hepatitis B Patients.
Huang Q, Zhou B, Cai D, Zong Y, Wu Y, Liu S
Hepatology. 2020; 73(1):41-52.
PMID: 32189364
PMC: 7898704.
DOI: 10.1002/hep.31240.
Mapping the Interactions of HBV cccDNA with Host Factors.
Mohd-Ismail N, Lim Z, Gunaratne J, Tan Y
Int J Mol Sci. 2019; 20(17).
PMID: 31480501
PMC: 6747236.
DOI: 10.3390/ijms20174276.
Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels.
Ko C, Chakraborty A, Chou W, Hasreiter J, Wettengel J, Stadler D
J Hepatol. 2018; 69(6):1231-1241.
PMID: 30142426
PMC: 7611400.
DOI: 10.1016/j.jhep.2018.08.012.
The Role of cccDNA in HBV Maintenance.
Allweiss L, Dandri M
Viruses. 2017; 9(6).
PMID: 28635668
PMC: 5490831.
DOI: 10.3390/v9060156.
Sustained Inhibition of HBV Replication In Vivo after Systemic Injection of AAVs Encoding Artificial Antiviral Primary MicroRNAs.
Maepa M, Ely A, Grayson W, Arbuthnot P
Mol Ther Nucleic Acids. 2017; 7:190-199.
PMID: 28624194
PMC: 5415967.
DOI: 10.1016/j.omtn.2017.04.007.
Hepatic deficiency of the pioneer transcription factor FoxA restricts hepatitis B virus biosynthesis by the developmental regulation of viral DNA methylation.
McFadden V, Shalaby R, Iram S, Oropeza C, Landolfi J, Lyubimov A
PLoS Pathog. 2017; 13(2):e1006239.
PMID: 28235042
PMC: 5342274.
DOI: 10.1371/journal.ppat.1006239.